@article{APS6330,
author = {Xin-zheng Lu and Jim-hong Wang and Xin Wu and Lei Zhou and Li Wang and Xiao-wen Zhang and Ke-jiang Cao and Jun Huang},
title = {Ginsenoside Rg1 promotes bone marrow stromal cells proliferation via the activation of the estrogen receptor-mediated signaling pathway},
journal = {Acta Pharmacologica Sinica},
volume = {29},
number = {10},
year = {2016},
keywords = {},
abstract = {Aim: To investigate the possible mechanisms of ginsenoside Rg1 promoting bone marrow stromal cell (BMSC) proliferation.
Methods: BMSC were isolated from bone marrow of Sprague-Dawley rats and maintained in vitro. After stimulation with 1 μmol/L ginsenoside Rg1 for the indicated time, the proliferation ability of BMSC were assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and [3 H]-thymidine incorporation assays. The estrogen receptor (ER) binding activity of BMSC was determined by a specific ER antagonist and an ER binding assay. Furthermore, the influence of ginsenoside Rg1 on the expression of ERα was investigated by RT-PCR and Western blotting assays.
Results: BMSC proliferation stimulated by 1 μmol/L ginsenoside Rg1 can be completely blocked by 1 μmol/L ER antagonist ICI 182, 780, or ERα-specific antagonist methylpiperidinopyrazole. Moreover, Rg1 failed to displace the specific binding of [3 H]17 β-estradiol to BMSC cell lysates, suggesting that no direct interaction of Rg1 with the ER is needed for its estrogenic effects. In addition, 1 μmol/L Rg1 had no effects on the expression of ERα in either the mRNA or protein levels.
Conclusion: Our results indicate that ERα is essential for mediating the effects of Rg1 on stimulating BMSC proliferation, which might involve the ligand/receptor-independent activation of ERα.},
issn = {1745-7254}, url = {http://www.chinaphar.com/article/view/6330}
}